Evofem Biosciences, Inc. SEC filings EVFM
Evofem Biosciences, Inc. has 802 filings in SEC EDGAR's recent list, going back to Sep 12, 2014. Its latest annual report, Form 10-K, was filed on Mar 11, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| D | Filing | Jul 2, 2025 | — |
| D | Filing | Apr 15, 2025 | — |
| D | Filing | Aug 21, 2024 | — |
| D | Filing | Aug 21, 2024 | — |
| D | Filing | Oct 11, 2023 | — |
| PRER14A | Filing | Aug 18, 2023 | — |
| EFFECT | Filing | Aug 14, 2023 | — |
| CORRESP | Letter to the SEC | Aug 10, 2023 | — |
| CORRESP | Letter to the SEC | Aug 3, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 19, 2023 | — |
| NT 10-Q | Filing | May 12, 2023 | Mar 31, 2023 |
| NT 10-K | Filing | Mar 31, 2023 | Dec 31, 2022 |
| D | Filing | Mar 6, 2023 | — |
| D | Filing | Feb 3, 2023 | — |
| NT 10-Q | Filing | Nov 14, 2022 | Nov 14, 2022 |
| 25-NSE | Delisting notice | Oct 27, 2022 | — |
| EFFECT | Filing | Sep 30, 2022 | — |
| CORRESP | Letter to the SEC | Sep 28, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 28, 2022 | — |
| EFFECT | Filing | Aug 5, 2021 | — |
| CORRESP | Letter to the SEC | Aug 3, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 3, 2021 | — |
| EFFECT | Filing | Mar 11, 2021 | — |
| CORRESP | Letter to the SEC | Mar 9, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 9, 2021 | — |
| D | Filing | Oct 16, 2020 | — |
| D | Filing | May 6, 2020 | — |
| 8-A12B | Filing | Mar 25, 2020 | — |
| EFFECT | Filing | Dec 2, 2019 | — |
| CORRESP | Letter to the SEC | Nov 26, 2019 | — |
| UPLOAD | Letter from the SEC | Nov 26, 2019 | — |
| EFFECT | Filing | Jul 2, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 28, 2019 | — |
| CORRESP | Letter to the SEC | Jun 28, 2019 | — |
| RW | Filing | Jun 24, 2019 | — |
| DEFR14A | Filing | May 10, 2019 | — |
| EFFECT | Filing | May 7, 2019 | — |
| CORRESP | Letter to the SEC | May 3, 2019 | — |
| UPLOAD | Letter from the SEC | May 3, 2019 | — |
| D | Filing | Apr 22, 2019 | — |
| D | Filing | Feb 14, 2019 | — |
| POS EX | Filing | May 22, 2018 | — |
| EFFECT | Filing | May 21, 2018 | — |
| CORRESP | Letter to the SEC | May 17, 2018 | — |
| CORRESP | Letter to the SEC | May 17, 2018 | — |
| UPLOAD | Letter from the SEC | May 17, 2018 | — |
| RW | Filing | May 16, 2018 | — |
| EFFECT | Filing | May 2, 2018 | — |
| EFFECT | Filing | Apr 3, 2018 | — |
| CORRESP | Letter to the SEC | Apr 2, 2018 | — |
| CORRESP | Letter to the SEC | Mar 27, 2018 | — |
| UPLOAD | Letter from the SEC | Mar 26, 2018 | — |
| 425 | Filing | Jan 5, 2018 | — |
| 425 | Form 8-k | Jan 5, 2018 | — |
| 425 | Form 8-k | Jan 4, 2018 | — |
| EFFECT | Filing | Dec 12, 2017 | — |
| CT ORDER | Filing | Nov 28, 2017 | — |
| 425 | Filing | Nov 8, 2017 | — |
| 425 | Form 8-k/a | Oct 31, 2017 | — |
| 425 | 8-k | Oct 17, 2017 | — |
| EFFECT | Filing | Dec 10, 2015 | — |
| CORRESP | Letter to the SEC | Dec 9, 2015 | — |
| UPLOAD | Letter from the SEC | Dec 9, 2015 | — |
| CT ORDER | Filing | Nov 21, 2014 | — |
| CERTNAS | Auto-generated paper document | Nov 19, 2014 | — |
| EFFECT | Filing | Nov 19, 2014 | — |
| 8-A12B | Filing | Nov 18, 2014 | — |
| CORRESP | Letter to the SEC | Nov 17, 2014 | — |
| CORRESP | Letter to the SEC | Nov 17, 2014 | — |
| CORRESP | Letter to the SEC | Nov 7, 2014 | — |
| UPLOAD | Letter from the SEC | Nov 7, 2014 | — |
| CORRESP | Letter to the SEC | Oct 27, 2014 | — |
| CORRESP | Letter to the SEC | Oct 17, 2014 | — |
| UPLOAD | Letter from the SEC | Oct 10, 2014 | — |
| DRS | Filing | Sep 12, 2014 | — |
Showing 75 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- EVFM (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1618835
- Former names
- Neothetics, Inc. (until Jan 5, 2018)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.